Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

Phase 3 Completed 384 enrolled Samsung Medical Center HK inno.N Corporation · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was designed to evaluate the treatment efficacy and safety of palonosetron for the patients who undergo laparoscopic gynecologic, abdominal or other surgery under general anesthesia.

Timeline

Start: 2012-01
Primary completion: 2012-06
Completion: 2012-06

Publications

Hahm TS, Hwang JW, Kim WH, Oh EJ, Kim DK, Choi WJ, Kim YH, Ryu JH, Yoo BH, Yon JH. A prospective, randomized, double-blind, multicenter trial to evaluate the therapeutic efficacy and safety of palonosetron in the treatment of postoperative nausea and vomiting over a 72-h period. J Anesth. 2015 Feb;29(1):21-8. doi: 10.1007/s00540-014-1884-9. Epub 2014 Jul 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Palonosetron	Other / unclassified	0.075 mg	Intravenous

Indications

No indication recorded.